Jun 10, 2016AAT Presentation14th International Symposium on Advances in Alzheimer Therapy, Athens, GreeceChristopher U. Missling, PhDView Presentation
14th International Symposium on Advances in Alzheimer Therapy, Athens, GreeceChristopher U. Missling, PhDView Presentation
Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA
Anavex Life Sciences Announces Acceptance of Peer-Reviewed Manuscript of Oral Blarcamesine Phase IIb/III Data in a Reference Alzheimer’s Disease Journal
